4.7 Article

Interaction of the renin inhibitor aliskiren with the SARS-CoV-2 main protease: a molecular docking study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Numeric analysis of reversibility of classic movement equations and constructive criteria of estimating quality of molecular dynamic simulations

Ivan Yu. Torshin et al.

Summary: The paper discusses the fundamental criteria for the quality of molecular dynamics simulations and presents constructive criteria for evaluating trajectory quality. Testing these criteria on small protein structures showed their usefulness for solving various MD problems.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Article Biochemical Research Methods

Discovery of Potent SARS-CoV-2 Inhibitors from Approved Antiviral Drugs via Docking and Virtual Screening

Samir Chtita et al.

Summary: This study used virtual screening and molecular docking methods to identify potential inhibitors from existing drugs that can effectively fight against COVID-19. A total of 129 approved drugs were analyzed, and 5 promising drugs were found to tightly bind to the main protease of the SARS-CoV-2 virus. Further in vivo testing is needed to confirm their efficacy as clinical drugs.

COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2021)

Article Biochemistry & Molecular Biology

Computational discovery of small drug-like compounds as potential inhibitors of SARS-CoV-2 main protease

Alexander M. Andrianov et al.

Summary: A computational approach was used to identify small drug-like compounds mimicking X77 for SARS-CoV-2 M-Pro inhibition. Five top-ranking compounds with high binding affinity to M-Pro were predicted, showing potential as scaffolds for novel antiviral agents targeting the active site of SARS-CoV-2 M-Pro.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Article Biochemistry & Molecular Biology

SARS-CoV-2 Mpro inhibitors and activity-based probes for patient-sample imaging

Wioletta Rut et al.

Summary: A team of researchers synthesized a new type of antiviral agent, demonstrating through experiments its high efficacy in inhibiting SARS-CoV-2 with a low effective concentration, providing new insights for antiviral treatment. By observing the active SARS-CoV-2 M-pro in the cells of patients infected with COVID-19, important clues were provided for the design of antiviral drugs and diagnostic tests.

NATURE CHEMICAL BIOLOGY (2021)

Review Pharmacology & Pharmacy

Antiretrovirals for Prophylaxis Against COVID-19: A Comprehensive Literature Review

Golbarg Alavian et al.

Summary: There is currently no definitive evidence to support the use of antiretrovirals (ARVs) for prophylaxis against COVID-19. Limited clinical evidence suggests that some ARVs may have a prophylactic role when used early in the course of the disease.

JOURNAL OF CLINICAL PHARMACOLOGY (2021)

Article Medicine, Research & Experimental

Functional and molecular evaluation of using aliskiren during acute and chronic partial ureteral obstruction in rat solitary kidney

Mohamed Essam et al.

Summary: The study showed that aliskiren significantly improved renal function, reduced necrosis and inflammatory cell infiltration in the cortex and medulla during acute and chronic partial ureteral obstruction in rat solitary kidney. Aliskiren also upregulated BCL-2 and downregulated IL-6, TGF-beta 1, collagen I, and fibronectin gene expression, while increasing GSH and SOD activity and reducing MDA and NO activity, leading to a more renoprotective effect when administered for four weeks compared to two weeks.

LIFE SCIENCES (2021)

Article Biochemistry & Molecular Biology

Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system

Man Lung Yeung et al.

Summary: Research has identified the crucial role of human host factors and sACE2 protein in virus dependency factors, cell entry, and other aspects of SARS-CoV-2 infection, shedding light on the pathogenesis of COVID-19 and potential treatment strategies.
Article Biochemical Research Methods

Effect of nelfinavir stereoisomers on coronavirus main protease: Molecular docking, molecular dynamics simulation and MM/GBSA study

Mohsen Sargolzaei

Summary: This study evaluated the binding strength of 32 diastereomers of nelfinavir against main protease using molecular docking and molecular dynamics simulation. Results showed that the RSRSR stereoisomer of nelfinavir exhibited higher protein stability and binding strength, with main contributions from vdW and electronic terms. The RSRSR diastereomer may be effective in the treatment of COVID-19.

JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2021)

Article Multidisciplinary Sciences

Effect of renin-angiotensin-aldosterone system inhibitors on Covid-19 patients in Korea

Jungchan Park et al.

Summary: This study found that the use of RAAS inhibitors did not increase mortality in Covid-19 patients compared to other antihypertensive drugs. The rate of ventilator care also showed no significant difference between the two groups. Therefore, it is suggested that RAAS inhibitors can be safely continued in Covid-19 patients.

PLOS ONE (2021)

Article Virology

Repurposing of renin inhibitors as SARS-COV-2 main protease inhibitors: A computational study

Rana H. Refaey et al.

Summary: The COVID-19 pandemic has led to the repurposing of existing drugs, with renin inhibitors showing potential as inhibitors of the main protease of SARS-CoV-2. Virtual screening and molecular docking indicated that remikiren could interact well with the catalytic site of the main protease, suggesting its stability as a potential treatment option.

VIROLOGY (2021)

Review Physiology

Controversial Roles of the Renin Angiotensin System and Its Modulators During the COVID-19 Pandemic

Simon B. Gressens et al.

Summary: This review explores the risks of using RAAS blockers for patients with cardiovascular comorbidities during the COVID-19 pandemic, investigates the impact of RAAS blockers on viral cell entry, and discusses how to maintain the balance between ACE2 and ACE and the effect of RAAS blockers on the course and prognosis of COVID-19 treatment.

FRONTIERS IN PHYSIOLOGY (2021)

Article Medicine, Research & Experimental

Impact of renin-angiotensin system inhibitors on mortality during the COVID Pandemic among STEMI patients undergoing mechanical reperfusion: Insight from an international STEMI registry

Giuseppe De Luca et al.

Summary: This study investigated the impact of RASI therapy on the prognosis and SARSCoV2 infection of STEMI patients undergoing PPCI during the COVID-19 pandemic. Both pre-admission and in-hospital RASI were associated with lower mortality. Among SARSCoV2-positive patients, both chronic and in-hospital RASI therapy showed no impact on survival.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Article Cardiac & Cardiovascular Systems

The Renin-Angiotensin-Aldosterone System and Coronavirus Disease 2019

Eliecer Coto et al.

Summary: RAAS is crucial in COVID-19 pathogenesis, with lower levels of ACE2 increasing susceptibility to infection. Antihypertensive drugs targeting RAAS do not significantly affect disease outcome, while variations in RAAS genes may partly explain heterogeneous response to SARS-CoV-2 infection.

EUROPEAN CARDIOLOGY REVIEW (2021)

Article Pharmacology & Pharmacy

Identification of potential COVID-19 main protease inhibitors using structure-based pharmacophore approach, molecular docking and repurposing studies

Safa Daoud et al.

Summary: This study utilized the X-ray crystallographic structure of COVID-19 main protease (Mpro) to generate a pharmacophore model and conducted a docking study to identify five FDA-approved antiviral drugs as potential COVID-19 main protease inhibitors. Three of these drugs (remdesivir, lopinavir, and ritonavir) showed promising results in COVID-19 treatment.

ACTA PHARMACEUTICA (2021)

Review Chemistry, Medicinal

The use of aliskiren as an antifibrotic drug in experimental models: A systematic review

Thaina Altarejo Marin et al.

DRUG DEVELOPMENT RESEARCH (2020)

Review Cardiac & Cardiovascular Systems

Clinical efficacy, safety and tolerability of Aliskiren Monotherapy (AM): an umbrella review of systematic reviews

Qiyuan Zhao et al.

BMC CARDIOVASCULAR DISORDERS (2020)

Review Biochemistry & Molecular Biology

Aliskiren ? A promising antioxidant agent beyond hypertension reduction

Saeed Alshahrani

CHEMICO-BIOLOGICAL INTERACTIONS (2020)

Article Medicine, General & Internal

The renin-angiotensin system - a therapeutic target in COVID-19?

Beattie R. H. Sturrock et al.

CLINICAL MEDICINE (2020)

Article Infectious Diseases

Lack of antiviral activity of darunavir against SARS-CoV-2

Sandra De Meyer et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)

Article Multidisciplinary Sciences

Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors

Zhenming Jin et al.

NATURE (2020)

Letter Cardiac & Cardiovascular Systems

Interaction between RAAS inhibitors and ACE2 in the context of COVID-19

Jean-Jacques Mourad et al.

NATURE REVIEWS CARDIOLOGY (2020)

Article Multidisciplinary Sciences

Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease

Lifeng Fu et al.

NATURE COMMUNICATIONS (2020)

Article Multidisciplinary Sciences

Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease

Alice Douangamath et al.

NATURE COMMUNICATIONS (2020)

Article Biochemistry & Molecular Biology

Identification of saquinavir as a potent inhibitor of dimeric SARS-CoV2 main protease through MM/GBSA

Martiniano Bello et al.

JOURNAL OF MOLECULAR MODELING (2020)

Article Biochemistry & Molecular Biology

A perspective on potential target proteins of COVID-19: Comparison with SARS-CoV for designing new small molecules

Devendra Kumar et al.

BIOORGANIC CHEMISTRY (2020)

Article Oncology

Aliskiren targets multiple systems to alleviate cancer cachexia

Chaoyi Wang et al.

ONCOLOGY REPORTS (2016)

Review Pharmacology & Pharmacy

Safety and efficacy of aliskiren in the treatment of hypertension: a systematic overview

Fabio Angeli et al.

EXPERT OPINION ON DRUG SAFETY (2012)

Review Pharmacology & Pharmacy

Aliskiren as a novel therapeutic agent for hypertension and cardio-renal diseases

Azhar Rashikh et al.

JOURNAL OF PHARMACY AND PHARMACOLOGY (2012)

Review Medicine, General & Internal

Oral renin inhibitors

Jan A. Staessen et al.

LANCET (2006)

Article Chemistry, Multidisciplinary

Molecular modeling of organic and biomolecular systems using BOSS and MCPRO

WL Jorgensen et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)

Article Chemistry, Physical

Free energies of hydration from a generalized Born model and an ALL-atom force field

WL Jorgensen et al.

JOURNAL OF PHYSICAL CHEMISTRY B (2004)